Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03316053 · ClinicalTrials.gov registry record
Cell Marker Predictors in Barrett's Esophagus
A clinical trial of Barrett's Esophagus Without Dysplasia, sponsored by The Guthrie Clinic.
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03316053: Active study of Barrett's Esophagus Without Dysplasia, sponsored by The Guthrie Clinic.
NCT03316053 is a study of Barrett's Esophagus Without Dysplasia that is active but no longer recruiting, run by The Guthrie Clinic. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03316053, a study of Barrett's Esophagus Without Dysplasia, is active but no longer recruiting, sponsored by The Guthrie Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
Primary Outcome
Identify genes involved in Barrett's Esophagus
Conditions Studied
Interventions
- OTHER Tissue sample for genetic testing
Study Locations (1)
Pennsylvania
- The Guthrie Clinic - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2027-12-01 |
What the registry record for NCT03316053 still lists
NCT03316053 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Barrett's Esophagus Without Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Tissue sample for genetic testing is the first listed.
NCT03316053 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03316053 about?
NCT03316053 is a clinical study titled "Cell Marker Predictors in Barrett's Esophagus". The purpose of this study is to analyze biopsied tissue samples for changes in cells and genes involved in Barrett's Esophagus.
What is the current status of trial NCT03316053?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2017-11-15. Estimated completion is 2027-12-01.
What conditions does trial NCT03316053 study?
This clinical trial studies the following conditions: Barrett's Esophagus Without Dysplasia.
What interventions are being tested in trial NCT03316053?
The interventions under investigation include: Tissue sample for genetic testing (OTHER).
Who is sponsoring clinical trial NCT03316053?
This trial is sponsored by The Guthrie Clinic, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03316053 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus Without Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI